[All-trans-retinol (atR) inhibits expression of the metalloproteinase stromelysin in retinal pigment epithelium

C L Schönfeld1

  • 1Augenklinik der Ludwig Maximilians Universität München. cschoenf@ak-i.med.uni-muenchen.de

Abstract

Insights

All-trans-Retinal (atR) reduces stromelysin gene expression in retinal pigment epithelial cells. This finding may explain how retinal cells detach, contributing to proliferative vitreoretinopathy (PVR) development.

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Molecular Biology

Context:

  • Proliferative vitreoretinopathy (PVR) is a complex condition involving retinal cell detachment.
  • The precise mechanisms leading to retinal cell release remain unclear.
  • Stromelysin, a matrix metalloproteinase, degrades extracellular matrix (ECM) proteins, potentially liberating retinal cells.

Purpose:

  • To investigate the effect of all-trans-Retinal (atR) on stromelysin gene expression in human retinal pigment epithelial (RPE) cells.
  • To determine if atR modulates the expression of stromelysin, an enzyme implicated in ECM degradation.

Summary:

  • Human RPE cells were cultured and treated with tetraphorbolester (TPA) alone or in combination with atR.
  • Reverse transcriptase-polymerase chain reaction was used to quantify stromelysin gene expression.
  • TPA significantly increased stromelysin expression, while co-incubation with atR attenuated this increase.

Impact:

  • atR significantly lowers stromelysin gene expression in RPE cells.
  • This downregulation suggests a potential inhibitory role of atR in the early stages of PVR.
  • Understanding this mechanism could lead to novel therapeutic strategies for PVR by targeting RPE cell dedifferentiation and ECM remodeling.

Related Concept Videos